Literature DB >> 15170719

Utility of IVUS-guided transaccess catheter in the treatment of long chronic total occlusion of the superficial femoral artery.

Ivan P Casserly1, Ravish Sachar, Christopher Bajzer, Jay S Yadav.   

Abstract

Failure to reenter the true lumen distal to an occlusion is the most frequent cause of failure of the technique of subintimal angioplasty. We report the utility of an IVUS-guided TransAccess catheter in overcoming this problem in the treatment of two patients with long chronic total occlusion of the superficial femoral artery. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2004        PMID： 15170719     DOI： 10.1002/ccd.20051

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  4 in total

Review 1.  Applications of grayscale and radiofrequency intravascular ultrasound to image atherosclerotic plaque.

Authors:  Somjot S Brar; Gary S Mintz; Akiko Maehara; Gregg W Stone
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  Real-time magnetic resonance imaging-guided endovascular recanalization of chronic total arterial occlusion in a swine model.

Authors:  Amish N Raval; Parag V Karmarkar; Michael A Guttman; Cengizhan Ozturk; Smita Sampath; Ranil DeSilva; Ronnier J Aviles; Minnan Xu; Victor J Wright; William H Schenke; Ozgur Kocaturk; Alexander J Dick; Venkatesh K Raman; Ergin Atalar; Elliot R McVeigh; Robert J Lederman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

3.  Re-entry devices in the treatment of peripheral chronic occlusions.

Authors:  Marcus Smith; Reji Pappy; Thomas A Hennebry
Journal:  Tex Heart Inst J       Date:  2011

4.  Retrograde distal superficial femoral artery approach in the supine position for chronic superficial femoral artery occlusion.

Authors:  Sanghoon Shin; Seunghwan Kim; Young-Guk Ko; Myeung-Ki Hong; Yangsoo Jang; Donghoon Choi
Journal:  Korean Circ J       Date:  2014-05-20       Impact factor: 3.243
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.